| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| chlorhexidingluconat 0,12 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| chlorhexidingluconat 1,2 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Natamycin 5% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| clioquinol + hydrocortison + pramoxinhydrochlorid 3 % wt/wt/1 % wt/wt/0,5 % wt/wt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| clioquinol 3 % wt/wt + hydrocortison 0,5 % wt/wt creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| clioquinol + hydrocortison 3 % wt/wt/0,5 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Clioquinol + hydrocortisone 30mg/10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| nystatin 100.000 enheder + triamcinolonacetonid 1 mg creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| nystatin 100.000 enheder + triamcinolonacetonid 1 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| nystatin 10.000 enheder + triamcinolonacetonid 1 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Terbinafine hydrochloride 1% spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Clioquinol+flumethasone pivalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing nystatin and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing ascorbic acid and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tolnaftate+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| chloroxylenol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing nystatin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| clioquinol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing capsaicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing methoxsalen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| nystatin 100.000 enheder/ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing witch hazel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing aluminium sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| hvid vaseline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| dimeticoncreme til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| sterile hudadhæsionsmidler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| sclerosant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Terbinafine (as terbinafine hydrochloride) 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tazaroten 0,05 % vandig gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tazaroten 0,1 % vandig gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| bivirkning af bromid |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| bivirkning af carbromalderivater |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Adverse reaction caused by antipruritic (disorder) |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Adverse reaction to local astringents and local detergents |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Adverse reaction to emollients, demulcents and protectants |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing allantoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing trichloroacetic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Adverse reaction to bromine compounds NOS |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Adverse reaction to other skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Adverse reaction to skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs NOS |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| N-butyl-cyanoacrylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+lignocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| fluocinolonacetonid 0,025 % + clioquinol 3 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| fluocinolonacetonid 0,025 % + clioquinol 3 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| destilleret troldnød 13 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tacrolimusmonohydrat 0,03 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tacrolimusmonohydrat 0,1 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| calcipotriol 50 µg + betamethason 500 µg/g salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Terbinafine hydrochloride 10 mg/mL cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| N-butyl-cyanoacrylate tissue adhesive |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,2 % mundskyllevæske med anissmag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Chlorhexidine 0.5% powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,2 % + lidocainhydrochlorid 0,05 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podophyllin |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| alopecimiddel |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podophyllotoxin |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Bentoquatam (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| skarlagenrød |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| formeringsmiddel |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Lithium succinate (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and ethanol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| chlorhexidingluconat 1 % + ethylalkohol 61 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing talc (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| sterilt talcumpudder 5 g/100 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Sclerosol intrapleural aerosol 4g sterile talc powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tazaroten 0,1 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| ammoniumlactat 12 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| terbinafinhydrochlorid 1 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| miconazolnitrat 200 mg/2 % vagitorium + 2 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing miconazole and tioconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| miconazol 1.200 mg vaginalindlæg + miconazol 2,0 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing alitretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tacrolimus 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tretinoin 400 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing perfluoroalkylpolyether and polytetrafluoroethylene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| perfluoralkylpolyether 50 %/polytetrafluorethylen 50 %, 84 g pasta til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| tazaroten 0,05 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing camphor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing camphor and menthol and phenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| aluminiumchlorid + alkohol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| biologisk lim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| sulfacetamidsulfat + svovl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing menthol and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Camphor + eucalyptus + menthol (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing camphor and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Tacrolimus 0.03% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Retinoid (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podophyllotoxin adverse reaction |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Allergy to podophyllotoxin |
Causative agent |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podophyllotoxin 5 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Podophyllotoxin 1.5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| clobetasonbutyrat + oxytetracyclin + nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and isopropyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
FHIR